Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial

Although national guidelines for cancer genetic risk assessment (CGRA) for hereditary breast and ovarian cancer (HBOC) have been available for over two decades, less than half of high-risk women have accessed these services, especially underserved minority and rural populations. Identification of high-risk individuals is crucial for cancer survivors and their families to benefit from biomedical advances in cancer prevention, early detection, and treatment.

Source: Contemporary Clinical Trials - September 17, 2018 Category: Radiology Authors: Anita Y. Kinney, Rachel Howell, Rachel Ruckman, Jean A. McDougall, Tawny W. Boyce, Belinda Vicu ña, Ji-Hyun Lee, Dolores D. Guest, Randi Rycroft, Patricia A. Valverde, Kristina M. Gallegos, Angela Meisner, Charles L. Wiggins, Antoinette Stroup, Lisa E. P Source Type: research